More than glycemic control: SGLT2 inhibitors may extend lung cancer survival
A retrospective study offers hope
#171 – Steve Austad, Ph.D.: The landscape of longevity science: making sense of caloric restriction, biomarkers of aging, and possible geroprotective molecules
“I never thought [extending the human lifespan] was going to happen because we got better at treating cancer or we got better at preventing heart disease. I always thought it was going to happen because we would develop something … that would fundamentally change the rate of aging. And we haven’t developed that yet. We’ve got a lot of clues and I think we’re getting closer and closer and closer.” —Steve Austad
Replacing sugar with allulose
Allulose is on the top of my sweetener preference list for both objective and subjective reasons.
A few things worth sharing: 10-04-2020
Longevity in mice; The wonders of F1.